학술논문
Predictors of Poor Very Early Diuretic Response and Effectiveness of Early Tolvaptan in Symptomatic Acute Heart Failure.
Document Type
Article
Author
Source
Subject
*RESEARCH
*FUROSEMIDE
*GLOMERULAR filtration rate
*INTRAVENOUS therapy
*CONFIDENCE intervals
*HETEROCYCLIC compounds
*TIME
*RETROSPECTIVE studies
*RISK assessment
*DIURESIS
*DESCRIPTIVE statistics
*VASOPRESSIN
*ODDS ratio
*EARLY medical intervention
*HEART failure
*SYMPTOMS
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1175-3277
Abstract
Background: Diuretic response (DR) in patients with symptomatic acute decompensated heart failure (ADHF) has an impact on prognosis. This study aimed to identify predictive factors influencing acute 6 h poor DR and to assess DR after early administration of tolvaptan (TLV). Methods: This multicenter retrospective study included 1670 patients who were admitted for ADHF and received intravenous furosemide within 1 h of presentation in clinical scenario 1 or 2 defined based on initial systolic blood pressure ≥100 mmHg with severe symptoms (New York Heart Association class III or IV (n = 830). The score for the poor DR factors in the very acute phase was calculated in patients treated with furosemide-only diuretics (n = 439). The DR to TLV administration was also assessed in patients who received an additional dose of TLV within 6 h (n = 391). Results: The time since discharge from the hospital for a previous heart failure < 3 months (odds ratio [OR] 2.78, 95% confidence interval [CI] 1.34–5.83; p = 0.006), loop diuretics at admission (OR 3.05, 95% CI 1.74–5.36; p < 0.0001), and estimated glomerular filtration rate (eGFR) < 45 mL/min/1.73 m2 (OR 2.99, 95% CI 1.58–5.74; p = 0.0007) were independent determinants of poor DR. The frequency of poor DR according to the risk stratification group was low risk (no risk factor), 18.9%; middle risk (one risk factor), 33.1%; and high risk (two to three risk factors), 58.0% (p < 0.0001). All risk groups demonstrated a significantly lower incidence of poor DR with early TLV administration: 10.7% in the early TLV group versus 18.9% in the loop diuretics group (p = 0.09) of the low-risk group; 18.4% versus 33.1% (p = 0.01) in the middle-risk group, and 20.2% versus 58.0% (p < 0.0001) in the high-risk group. Conclusion: Early administration of TLV in patients with predicted poor DR contributed to a significant diuretic effect and suppression of worsening renal function. [ABSTRACT FROM AUTHOR]